Steven Cohen’s Cabaletta Bio CABA Stock Holding History

Steven Cohen’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-246,615	Closed	-$663K	–	4048
2026 Q1	$663K	Buy	246,615 +189,967	+335%	+$527K	﹤0.01%	2997
2025 Q4	$124K	Buy	+56,648	New	+$140K	﹤0.01%	3713
2025 Q1	–	Sell	-1,265,882	Closed	-$2.87M	–	2077
2024 Q4	$2.87M	Buy	1,265,882 +598,607	+90%	+$2.1M	0.01%	1125
2024 Q3	$3.15M	Buy	+667,275	New	+$3.86M	0.01%	1023
2024 Q2	–	Sell	-282,651	Closed	-$4.82M	–	1896
2024 Q1	$4.82M	Sell	282,651 -2,015	-0.7%	-$43.2K	0.01%	976
2023 Q4	$6.46M	Buy	+284,666	New	+$4.79M	0.02%	828
2023 Q2	–	Sell	-5,243	Closed	-$43.4K	–	2211
2023 Q1	$43.4K	Buy	+5,243	New	+$49.1K	﹤0.01%	1811
2022 Q2	–	Sell	-725,000	Closed	-$1.47M	–	1418
2022 Q1	$1.47M	Sell	725,000 -225,000	-24%	-$588K	0.01%	915
2021 Q4	$3.6M	Buy	950,000 +50,000	+6%	+$534K	0.01%	738
2021 Q3	$10.9M	Buy	+900,000	New	+$8.3M	0.05%	463

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Steven Cohen's CABA Position: Q2 2026 in Review

Steven Cohen sold out of Cabaletta Bio (CABA) in Q2 2026, closing a stake of 246,615 shares — an estimated $663K sold.

Steven Cohen first reported a position in CABA in Q3 2021 and held it in 10 quarters. The position peaked at $10.9M in Q3 2021. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Steven Cohen reported no remaining Cabaletta Bio position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 246,615 Cabaletta Bio shares in Q2 2026, an estimated $663K.
Steven Cohen first reported a position in Cabaletta Bio in Q3 2021 and held it in 10 quarters.
Steven Cohen's Cabaletta Bio position peaked at $10.9M in Q3 2021.
139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.